Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Secchiero, Paola ^a   Corallini, Federica ^a   Ceconi, Claudio ^b   Parrinello, Giovanni ^c   Volpato, Stefano ^a   Ferrari, Roberto ^b   Zauli, Giorgio ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; CREATINE KINASE MB; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL;

ANIMALIA;

EID: 84887212512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004442     Document Type: Article

References (32)

1. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, et al. (2005) Tumor Necrosis Factor-α Receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction. Circulation 111: 863-870.
2. Jeremias I, Kupatt C, Martin-Villalba A, Habazettl H, Schenkel J, et al. (2000) Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 102: 915-920.
3. Nakajima H, Yanase N, Oshima K, Sasame A, Hara T, et al. (2003) Enhanced expression of the apoptosis inducing ligand TRAIL in mononuclear cells after myocardial infarction. Jpn Heart J 44: 833-844.
4. Liao X, Wang X, Gu Y, Chen Q, Chen LY (2005) Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis. Life Sci 77: 160-174.
5. Michowitz Y, Goldstein E, Roth A, Afek A, Abashidze A, et al. (2005) The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. J Am Coll Cardiol 45: 1018-1024.
6. Schoppet M, Sattler AM, Schaefer JR, Hofbauer LC (2006) Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis. Atherosclerosis 184: 446-447.
7. Zauli G, Secchiero P (2006) The role of the TRAIL/TRAIL-receptors system in hematopoiesis and endothelial cell biology. Cyt Gr Fact Rev 17: 245-257.
8. Secchiero P, Zerbinati C, Rimondi E, Corallini F, Milani D, et al. (2004) TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. Cell Mol Life Sci 61: 1965-1974.
9. Siegmund D, Klose S, Zhou D, Baumann B, Röder C, et al. (2007) Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells. Cell Signal 19: 1172-1184.
10. Kavurma MM, Schoppet M, Bobryshev YV, Khachigian LM, Bennett MR (2008) TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappaB and induction of insulin-like growth factor-1 receptor. J Biol Chem 283: 7754-7762.
11. Song JJ, Lee YJ (2008) Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamily. Cell Signal 20: 892-906.
12. Belyanskaya LL, Ziogas A, Hopkins-Donaldson S, Kurtz S, Simon HU, et al. (2008) TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8. Lung Cancer 60: 355-365.
13. Zhang XD, Nguyen T, Thomas WD, Sanders JE, Hersey P (2000) Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett 483: 193-199.
14. Secchiero P, Gonelli A, Carnevale E, Milani D, Pandolfi A, et al. (2003) TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 107: 2250-2256.
15. Li JH, Kirkiles-Smith NC, McNiff JM, Pober JS (2003) TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells. J Immunol 171: 1526-1533.
16. Zauli G, Pandolfi A, Gonelli A, Di Pietro R, Guarnieri S, et al. (2003) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. Circ Res 92: 732-740.
17. Pritzker LB, Scatena M, Giachelli CM (2004) The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. Mol Biol Cell 15: 2834-2841.
18. Alladina SJ, Song JH, Davidge ST, Hao C, Easton AS (2005) TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2. J Vasc Res 42: 337-347.
19. Secchiero P, Corallini F, di Iasio MG, Gonelli A, Barbarotto E, et al. (2005) TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release. Blood 105: 3413-3419.
20. Chen PL, Easton A (2008) Apoptotic phenotype alters the capacity of tumor necrosis factor-related apoptosis-inducing ligand to induce human vascular endothelial activation. J Vasc Res 45: 111-122.
21. Secchiero P, Candido R, Corallini F, Zacchigna S, Toffoli B, et al. (2006) Systemic TRAIL delivery shows anti-atherosclerotic activity in apoE-null diabetic mice. Circulation 114: 1522-1530.
22. Ladenson JH (2007) A personal history of markers of myocyte injury (myocardial infarction). Clin Chim Acta 381: 3-8.
23. Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M (2008) Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 21: 733-741.
24. Cassatella MA, Huber V, Calzetti F, Margotto D, Tamassia N, et al. (2006) Interferon-activated neutrophils store a TNF-related apoptosis inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. J Leuk Biol 79: 123-132.
25. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, et al. (1998) Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32: 368-372.
26. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, et al. (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell derived factor-1. J Biol Chem 276: 43503-43508.
27. Niormoi O, Mills L, Bar-Eli M (2003) An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells. Cell Death Differ 10: 558-569.
28. Renshaw SA, Parmar JS, Singleton V, Rowe SJ, Dockrell DH, et al. (2003) Acceleration of human neutrophil apoptosis by TRAIL. J Immunol 170: 1027-1033.
29. Lum JJ, Bren G, McClure R, Badley AD (2005) Elimination of senescent neutrophils by TNF-related apopotosis-inducing ligand. J Immunol 175: 1232-1238.
30. Takahashi T, Hiasa Y, Ohara Y, Miyazaki S, Ogura R, et al. (2007) Relation between neutrophil counts on admission, microvascular injury, and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty. Am J Cardiol 100: 35-40.
31. Dragu R, Huri S, Zuckerman R, Suleiman M, Mutlak D, et al. (2008) Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis 196: 405-412.
32. Nomura S, Ishii K, Inami N, Uoshima N, Ishida H, et al. (2007) Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation. Transplant Immunol 18: 115-121.